And as expected, binding of miR-143 to the 3′-UTR of MSI2 mRNA was validated by luciferase reporter assay, providing evidence that miR-143 reversed the role of MSI2 in AML development. The gene discussed is MSI2; the disease is acute myeloid leukemia.